Clinical trials in the Middle East and North Africa (MENA) Region: Grandstanding or Grandeur?

Contemporary Clinical Trials

Volumn 36, Issue 2, 2013, Pages 704-710

  Nair, Satish Chandrasekhar ^a   Ibrahim, Halah ^a   Celentano, David D ^b  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Clinical trials; Disease pool; Gas price index; Middle East North Africa; Recruitment; Regulatory

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COST CONTROL; DRUG INDUSTRY; FEMALE; GOOD CLINICAL PRACTICE; HEALTH CARE; HEALTH LITERACY; HUMAN; INFORMED CONSENT; MALE; MARKET; MEDICAL EDUCATION; MEDICAL SCHOOL; MIDDLE EAST; NORTH AFRICA; ORGANIZATION; PHYSICIAN; STRATEGIC PLANNING; TEACHING HOSPITAL;

CLINICAL TRIALS; DISEASE POOL; GAS PRICE INDEX; MIDDLE EAST NORTH AFRICA; RECRUITMENT; REGULATORY;

ADOLESCENT; ADULT; AFRICA, NORTHERN; AGED; CLINICAL TRIALS AS TOPIC; COST SAVINGS; DEVELOPING COUNTRIES; DRUG APPROVAL; DRUG INDUSTRY; FEMALE; HOSPITALS, TEACHING; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; MIDDLE EAST; PATIENT SELECTION; SCHOOLS, MEDICAL; YOUNG ADULT;

EID: 84888133080     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.05.009     Document Type: Article

References (34)

1. Smith W.T. FDA requires foreign clinical studies be in accordance with good clinical practices to better protect human subjects. ABA Health Source 2008, 5:1-3.
2. Rajadhyaksha V. Conducting feasibilities in clinical trials: an investment to ensure a good study. Perspect Clin Res 2010, 1:106-109.
3. Desai P.B., Anderson C., Sietsama W.K. A comparison of the quality of data assessed using query rates from clinical trials conducted across developed versus emerging regions. Drug Info J 2012, 46:455-463.
4. Misik V. Shifting sands. Eur Pharma Contract September 2011, 66-70.
5. Nair S.C. Clinical trials opportunities and challenges: Middle East and North Africa (MENA) Region. ACRP Annual Conference, Seattle, WA 10-15April 2011, paper noS702 2011, ACRP, Virginia. S. Kinkley (Ed.).
6. Al-Rawi Y., Al-Tajir G. MENA Region. ACRP Monitor September 2012, 33-37.
7. United Nations, Department of Economic and Social Affairs - Population Division, Population Estimates and Projections Section - World Population Prospects (2010 Revision) accessed December 30 2012.
8. Nair S.C. Critical components for the conduct of effective clinical trials in the UAE. Next Level Pharma conference on Achieving Clinical & Regulatory Excellence in Turkey, the Middle East & North Africa. Istanbul, Turkey, 7-9 June 2012, Paper no. G121 2012.
9. Nyka A., Kilama W., Ghilengi R., Tangwa G., Tindana P., Ndebele P., et al. Composition, training needs and independence of ethic review committees across Africa: are the gatekeepers rising to emerging challenges. J Med Ethics 2009, 35:189-193.
10. Nightingale S.L. Regulatory overview: protection of human subjects - IRBs and informed consents. Drug Info J 1987, 2:15-16.
11. Kegley J.A.K. Challenges to informed consent. EMBO 2004, 5:832-835.
12. Kapiszewski A. Arab versus Asian migrant workers in the GCC countries. Conference on Transnational Migration-Foreign Labor and Its Impact in the Gulf June 20-25, 2005, Bellagio Center, Italy.
13. Baker D.W., Parker R.M., Williams M.V., Pitkin K., Parikh N.S., Coates W., et al. The health care experience of patients with low literacy. Arch Fam Med 1996, 5:329-334.
14. Young R.A., Dehaven M.J., Passmore C., Baumer J.G. Research participation, protected time, and research output by family physicians in family medicine residencies. Fam Med 2006, 38:341-348.
15. Steensma D.P., Hoyer J.D., Fairbanks V.F. Hereditary red blood cell disorders in Middle Eastern patients. Mayo Clin Proc 2001, 76:85-93.
16. Center for Disease Control Update on overall prevalence of major birth defects. MMWR 2008, 57(01):1-5.
17. Al-Shahrani M. Steps toward the prevention of hemoglobinopathies in the kingdom of Saudi Arabia. Hemoglobin 2009, 33(Suppl. 1):S21-S24.
18. World Health Organization non-communicable diseases, Country profiles 2011 accessed December 31 2012.
19. Fuleihan G.E.H. Vitamin D, deficiency in the Middle East and its health consequences for children and adults. Clin Rev Bone Miner Metab 2009, 7:77-93.
20. Gannage-Yared M.H., Maalouf G., Khalife S., Challita S., Yaghi Y., Ziade N., et al. Prevalence and predictors of vitamin D inadequacy amongst Lebanese osteoporotic women Br. J. Nutr. 2009, 101:487-491.
21. Fahed A.C., El-Hage-Sleiman A.K.M., Farhat T.I., Nemer G.M. Diet, genetics, and disease: a focus on the Middle East and North Africa Region. J Nutr Metab 2012, 1-19.
22. Ramia S., Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 2006, 10(4):272-277.
23. Bassiony M.M. Smoking in Saudi Arabia. Saudi Med J 2009, 30:876-881.
24. Elsayed S.I., Jazieh A.R., Moore M.A. Lung cancer incidence in the Arab league countries; risk factors and control. Asia Pac J Cancer Prev 2011, 12:17-34.
25. Bansal N. The opportunities and challenges in conducting clinical trials globally. Clin Res Regul Aff 2012, 29:9-14.
26. Misik V. Expected growth of industry-sponsored clinical trials in the Middle East bench marked on other global regions [accessed August 2012]. http://www.quintiles.com/information-library/media-coverage.
27. Glickman S.W., McHutchison J.G., Peterson E.D., Caims C.B., Harrington R.A., Califf R.M., et al. Ethical and scientific implications of the globalization of clinical research. New England J. Med. 2009, 360:816-823.
28. Malakoff D. Clinical trials and tribulations: spiraling costs threaten gridlock. Science 2008, 322:210-213.
29. Emanuel E.J., Schnipper L.E., Kamin D.Y., Levinson J., Lichter A.S. The costs of conducting clinical research. J Clin Oncol 2003, 21:4145-4150.
30. Johnston S.C., Hauser S.L. Clinical trials cost: rising limit innovation. Ann Neurol 2007, 62(6):A6-A7.
31. World Bank Global indicator [information center OTA accessed December 30 2012]. http://data.worldbank.org/indicator/EP.PMP.SGAS.CD&AIT/FIA.
32. Ajmera R., Kook N., Crilley J. Impact of commodity price movements on CPI inflation. Mon Labor Rev April 2012, 29-41.
33. Sales forecast for Global Pharmaceutical Business [accessed October 29 2012]. http://www.statista.com/statistics/215817/sales-forecast-for-the-pharmaceutical-industry-worldwide-by-region/.
34. IMS Health The global use of medicines: outlook through 2016 [accessed October 29 2012]. http://www.imshealth.com/portal/site/ims/menuitem./?vgnextoid=4d47d1822e678310VgnVCM10000076192ca2RCRD.